S A Armentrout, C P Burns. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Administration, OralAdolescentAdultAge FactorsAgedAnemia/chemically inducedChildCytarabine/administration & dosageCytarabine/adverse effectsCytarabine/therapeutic useDNA, Neoplasm/biosynthesisFemaleHumansInjections, IntravenousLeukemia, Myeloid, Acute/bloodLeukemia, Myeloid, Acute/drug therapyLeukemia, Myeloid, Acute/mortalityLeukocytes/metabolismMaleMiddle AgedMuramidase/bloodNausea/chemically inducedRemission, SpontaneousSex FactorsThioguanine/administration & dosageThioguanine/therapeutic useThrombocytopenia/chemically inducedTime FactorsVomiting/chemically induced
Substances： See more » DNA, NeoplasmCytarabineMuramidaseThioguanine
Year: 1974 PMID： 4531223 DOI： 10.1097/00000441-197409000-00005
Source DB: PubMed Journal: Am J Med Sci ISSN： 0002-9629 Impact factor: 2.378